Immune function of erythrocytes in patients with chronic venous insufficiency of the lower extremities

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2224-2228

  Zhang, Lan ^a   Zhang, Bai Gen ^a   Zhang, Ji Wei ^a   Zhang, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Erythrocytes; Natural immunity; Venous insufficiency

Indexed keywords

BLOOD GROUP ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; FY6 ANTIGEN; INTERLEUKIN 8; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LEG VEIN; LIPODERMATOSCLEROSIS; PROTEIN BLOOD LEVEL;

EID: 38349179194     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00013     Document Type: Article

References (15)

1. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15: 175-184.
2. Fukuda S, Yasu T, Predescu DN, Schmid-Schonbein G. The regulation of leukocyte response to shear stress by nitric oxide and cGMP. Circ Res 2000; 86: E13-E16.
3. Takase S, Delano F, Lerond L, Bergan JJ, Schmid-Schonbein GW. Inflammation in chronic venous insufficiency: is the problem insurmountable? J Vasc Res 1999; 38(suppl 1): 3-10.
4. Azaceta G, Romero S, Moreno JA, Vaquerizo A, Olave T, Lorente C, et al. Hemorheological profile in chronic insufficiency after surgery. Hemostasis 1999; 29: 219-224.
5. Powell CC, Rohrer MJ, Barnard MR, Pevton BD, Furman MI, Michelson AD. Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation. J Vasc Surg 1999; 30: 844-851.
6. Siegel I, Liu TL, Gleicher N. The red cell immune system. Lancet 1981; 2: 556-559.
7. Porter JM, Moneta GL. Reporting Standards in venous disease: an update. International Consensus Committee on Chronic Venous Diseease. J Vasc Surg 1995; 21: 635-645.
8. Feng G. Experimental system of hematogenic immunoreaction road map activated by cancer cells. J Oncol 2005; 11: 309-311.
9. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy A. Cause of venous ulceration: a new hypotyesis. BMJ 1988; 296: 1726-1727.
10. Schmid-Schonbein GW, Takase S, Bergan JJ. New advance in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 2001; 52(suppl 1): S27-34.
11. Gianfrani C, Auricchio S, Troncone R. Adaptive and innate immune responses in celiac disease. Immunol Lett 2005; 99: 141-145.
12. Weisma HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Cincino MF, et al. Soluble human complement receptor type I: in vivo inhibitor of complement suppressing post ischemic myocardial inflammation and necrosis. Science 1990; 249: 146-151.
13. Dawson TC, Lentsch AB, Wang Z, Cowhiq JE, Rot A, Maeda N, et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/ receptor for chemokines (DARC). Blood 2000; 96: 1681-1684.
14. Nicolaides AN. Chronic venous disease and the leukocyte-endothelium interaction: from symptoms to ulceration. Angiology 2005; 56 (Suppl 1): S11-S19.
15. Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000; 14: 427-435.